Annual Non Current Assets
$4.03 M
-$1.30 M-24.40%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual long term assets is $4.03 million, with the most recent change of -$1.30 million (-24.40%) on December 31, 2023.
- During the last 3 years, ATOS annual non current assets has risen by +$3.96 million (+5744.93%).
- ATOS annual non current assets is now -24.40% below its all-time high of $5.33 million, reached on December 31, 2022.
Performance
ATOS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$2.37 M
-$1.77 M-42.85%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly long term assets is $2.37 million, with the most recent change of -$1.77 million (-42.85%) on September 30, 2024.
- Over the past year, ATOS quarterly non current assets has dropped by -$1.68 million (-41.54%).
- ATOS quarterly non current assets is now -55.65% below its all-time high of $5.33 million, reached on December 31, 2022.
Performance
ATOS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ATOS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.4% | -41.5% |
| 3 y3 years | +5744.9% | +6329.4% |
| 5 y5 years | +2264.0% | +6329.4% |
ATOS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | >+9999.0% | -55.6% | >+9999.0% |
| 5 y | 5-year | -24.4% | >+9999.0% | -55.6% | >+9999.0% |
| alltime | all time | -24.4% | >+9999.0% | -55.6% | >+9999.0% |
Atossa Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.37 M(-42.9%) |
| Jun 2024 | - | $4.14 M(+2.7%) |
| Mar 2024 | - | $4.03 M(-0.0%) |
| Dec 2023 | $92.22 M(-22.0%) | $4.03 M(-0.3%) |
| Sep 2023 | - | $4.05 M(+72.1%) |
| Jun 2023 | - | $2.35 M(-55.9%) |
| Mar 2023 | - | $5.33 M(-0.1%) |
| Dec 2022 | $118.20 M(-16.3%) | $5.33 M(+60.3%) |
| Sep 2022 | - | $3.33 M(+430.9%) |
| Jun 2022 | - | $627.00 K(-0.5%) |
| Mar 2022 | - | $630.00 K(+2763.6%) |
| Dec 2021 | $141.24 M(+230.2%) | $22.00 K(-40.2%) |
| Sep 2021 | - | $36.80 K(-0.8%) |
| Jun 2021 | - | $37.10 K(-24.6%) |
| Mar 2021 | - | $49.20 K(-28.7%) |
| Dec 2020 | $42.77 M(+198.7%) | $69.00 K(-42.2%) |
| Sep 2020 | - | $119.30 K(-17.2%) |
| Jun 2020 | - | $144.00 K(-0.8%) |
| Mar 2020 | - | $145.20 K(-14.9%) |
| Dec 2019 | $14.32 M(+24.0%) | $170.60 K(-12.9%) |
| Sep 2019 | - | $195.90 K(-11.4%) |
| Jun 2019 | - | $221.20 K(-9.8%) |
| Mar 2019 | - | $245.20 K(+43.7%) |
| Dec 2018 | $11.55 M(+46.2%) | $170.60 K(-15.3%) |
| Sep 2018 | - | $201.40 K(+18.7%) |
| Jun 2018 | - | $169.70 K(-30.7%) |
| Mar 2018 | - | $244.90 K(-8.0%) |
| Dec 2017 | $7.90 M | $266.10 K(-61.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $684.50 K(-6.6%) |
| Jun 2017 | - | $733.20 K(-6.8%) |
| Mar 2017 | - | $786.30 K(-11.6%) |
| Dec 2016 | $3.25 M(-24.2%) | $889.80 K(-48.1%) |
| Sep 2016 | - | $1.71 M(-6.3%) |
| Jun 2016 | - | $1.83 M(+6.7%) |
| Mar 2016 | - | $1.71 M(-12.0%) |
| Dec 2015 | $4.29 M(-54.0%) | $1.95 M(-30.8%) |
| Sep 2015 | - | $2.82 M(+0.3%) |
| Jun 2015 | - | $2.81 M(+15.2%) |
| Mar 2015 | - | $2.44 M(+0.5%) |
| Dec 2014 | $9.34 M(+38.1%) | $2.42 M(-52.1%) |
| Sep 2014 | - | $5.06 M(-1.7%) |
| Jun 2014 | - | $5.15 M(+9.9%) |
| Mar 2014 | - | $4.68 M(-10.8%) |
| Dec 2013 | $6.76 M(+239.9%) | $5.25 M(+7.4%) |
| Sep 2013 | - | $4.89 M(+4.0%) |
| Jun 2013 | - | $4.70 M(-1.0%) |
| Mar 2013 | - | $4.75 M(-1.9%) |
| Dec 2012 | $1.99 M(-32.5%) | $4.84 M(+0.6%) |
| Sep 2012 | - | $4.81 M(+3280.5%) |
| Jun 2012 | - | $142.20 K(-5.6%) |
| Mar 2012 | - | $150.70 K(+19.1%) |
| Dec 2011 | $2.95 M(>+9900.0%) | $126.50 K(+48.6%) |
| Sep 2011 | - | $85.10 K(+1672.9%) |
| Dec 2010 | $10.30 K | $4800.00(+336.4%) |
| Sep 2010 | - | $1100.00(0.0%) |
| Jun 2010 | - | $1100.00 |
FAQ
- What is Atossa Therapeutics annual long term assets?
- What is the all time high annual non current assets for Atossa Therapeutics?
- What is Atossa Therapeutics annual non current assets year-on-year change?
- What is Atossa Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly non current assets year-on-year change?
What is Atossa Therapeutics annual long term assets?
The current annual non current assets of ATOS is $4.03 M
What is the all time high annual non current assets for Atossa Therapeutics?
Atossa Therapeutics all-time high annual long term assets is $5.33 M
What is Atossa Therapeutics annual non current assets year-on-year change?
Over the past year, ATOS annual long term assets has changed by -$1.30 M (-24.40%)
What is Atossa Therapeutics quarterly long term assets?
The current quarterly non current assets of ATOS is $2.37 M
What is the all time high quarterly non current assets for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly long term assets is $5.33 M
What is Atossa Therapeutics quarterly non current assets year-on-year change?
Over the past year, ATOS quarterly long term assets has changed by -$1.68 M (-41.54%)